Collegium Pharmaceutical (COLL) Amortization - Intangibles (2019 - 2026)
Collegium Pharmaceutical (COLL) posted quarterly Amortization - Intangibles of $55.5 million for Q1 2026, little changed year-over-year from $55.5 million in Q1 2025, and little changed quarter-over-quarter from $55.5 million in Q4 2025.
Collegium Pharmaceutical (COLL) Amortization - Intangibles (2019 - 2026) Analysis & Trends
Collegium Pharmaceutical's Amortization - Intangibles history runs 8 years deep, the most recent figure standing at $55.5 million for Q1 2026.
- In Q1 2026, Amortization - Intangibles changed 0.0% year-over-year to $55.5 million; the TTM figure through Mar 2026 stood at $221.9 million (up 19.13% YoY), while the FY2025 annual figure was $221.9 million, up 34.23% from the prior year.
- Amortization - Intangibles for Q1 2026 stood at $55.5 million, roughly flat from $55.5 million in the prior quarter.
- The five-year high for Amortization - Intangibles was $55.5 million in Q1 2025, with the low at $18.9 million in Q1 2022.
- The 5-year median for Amortization - Intangibles is $37.6 million (2022), against an average of $42.6 million.
- The sharpest annual moves came in 2022 and 2023: Amortization - Intangibles soared 151.74% in 2022, then fell 18.37% in 2023.
- Collegium Pharmaceutical's Amortization - Intangibles stood at $42.3 million in 2022, then declined by 18.37% to $34.5 million in 2023, then jumped by 60.72% to $55.5 million in 2024, then climbed by 0.0% to $55.5 million in 2025, then changed by 0.0% to $55.5 million in 2026.
- Business Quant data shows COLL's Amortization - Intangibles at $55.5 million in Q1 2026, $55.5 million in Q4 2025, and $55.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - |
| 10 | Collegium Pharmaceutical | 879.69 Mn | 730.37 Mn | 110.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 62.95 Mn |
| Mar 31, 2026 | 55.47 Mn |
| Dec 31, 2025 | 55.47 Mn |
| Sep 30, 2025 | 55.47 Mn |
| Jun 30, 2025 | 55.47 Mn |
| Mar 31, 2025 | 55.47 Mn |
| Dec 31, 2024 | 55.47 Mn |
| Sep 30, 2024 | 40.80 Mn |
| Jun 30, 2024 | 34.52 Mn |
| Mar 31, 2024 | 34.52 Mn |
| Dec 31, 2023 | 34.51 Mn |
| Sep 30, 2023 | 36.32 Mn |
| Jun 30, 2023 | 37.46 Mn |
| Mar 31, 2023 | 37.47 Mn |
| Dec 31, 2022 | 42.28 Mn |
| Sep 30, 2022 | 37.55 Mn |
| Jun 30, 2022 | 37.50 Mn |
| Mar 31, 2022 | 18.92 Mn |
| Dec 31, 2021 | 16.80 Mn |
| Sep 30, 2021 | 16.80 Mn |